Quantcast

Latest Paliperidone Stories

2014-02-11 08:25:00

DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5nldqw/sustained_release ) has announced the addition of the "Sustained Release Injectables to 2020" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Formulations, Dosing, Devices, Markets and Forecasts The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency...

2013-11-05 23:26:47

The Agreement Settles Charges that Johnson & Johnson Illegally Marketed Risperdal, Invega and Natracor for Off-Label Use and Paid Kick-Backs to Physicians to Drive Sales of Risperdal and Invega, Alonso Krangle LLP reports. New York, NY (PRWEB) November 05, 2013 Johnson & Johnson has agreed to pay $2.2 billion to settle charges with the U.S. Department of Justice (DOJ) over the alleged illegal marketing of Risperdal, Invega and Natrecor, Alonso Krangle LLP reports. In a press...

2012-03-21 13:55:32

Physicians who prescribe antipsychotic medications may be basing their decisions on incomplete information, according to new research published by scientists at Oregon Health & Science University. The study is published in PLoS Medicine, a peer-reviewed open-access journal published by the Public Library of Science. This latest research follows a highly publicized 2008 report in the New England Journal of Medicine demonstrating that antidepressant drug trials were selectively...

2012-03-21 10:23:03

A study in this week's PLoS Medicine suggests that the apparent clinical effectiveness of the newer form of drugs used to treat schizophrenia and other psychotic illnesses (second-generation anti-psychotic drugs) may be enhanced by the selective reporting of trials of these drugs in medical journals — a phenomenon called publication bias. This finding is important as the results of published trials influence clinicians' decisions to prescribe drugs. The authors, led by Erick Turner...

2012-03-21 05:45:59

(Ivanhoe Newswire) — If you´re in pain, there´s a pill for that! But it may not always be good. A new study shows clinical effectiveness of the newer form of drugs used to treat schizophrenia and other psychotic illnesses may be enhanced by a phenomenon called publication bias. The study, led by Erick Turner from Oregon Health & Science University in Portland, shows selective reporting of research results undermines the integrity of the evidence base, which ultimately...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.